Gurien, Steven D
Aziz, Monowar
Jin, Hui
Wang, Haichao
He, Mingzhu
Al‐Abed, Yousef
Nicastro, Jeffrey M
Coppa, Gene F
Wang, Ping https://orcid.org/0000-0002-1557-0394
Funding for this research was provided by:
HHS | National Institutes of Health (R35GM118337)
HHS | National Institutes of Health (R01GM129633)
Article History
Received: 12 March 2019
Revised: 18 October 2019
Accepted: 24 October 2019
First Online: 14 November 2019
Conflict of interest
: One of the authors (PW) is an inventor of patent applications covering the fundamental concept of targeting CIRP for the treatment of inflammatory diseases, licensed by TheraSource LLC. PW is a co‐founder of TheraSource LLC. Other authors declared that they have no competing interests.